Sweden Analgesic Medicine Sales is set to reach $250.42 Million by 2026 from $253.66 Million, will rise 1.5% per year. Since 2017, the market grew 3.3% year on year close to $7,260 Million. Spain, Canada and Italy respectively ranked numbers 2, 3 and 4 in this ranking.
How does Sweden perform in Analgesic?
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Analgesic Medicine Sales in Sweden
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
- Million Swedish Kronas
- 2024 to 2028
- ReportLinker Research
Forecast: Analgesic Medicine Sales in Sweden
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Analgesic Medicine Sales in Sweden
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Analgesic Medicine Sales in Sweden
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Sweden
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research